Suministro de Tafamidis (DOE) y Crizotinib (DOE)

TED · 637581-2026Award noticeawardedNo deadline given

Buyer

NameOSAKIDETZA - Servicio Vasco de Salud - Organización Central

CountryES

Published2026-09-16

Deadline—

Value

Estimated€79,786,094 · 79,786,093.87 EUR

Awarded€66,488,412 · 66,488,411.56 EUR

WinnerPFIZER, S.L.

See this firm's wins →

Who already wins at this buyer

Firms with recorded awards from OSAKIDETZA - Servicio Vasco de Salud - Organización Central in this tender’s CPV categories — the incumbents you are bidding against.

Firm	Wins	Awarded	Last win
ASTRAZENECA FARMACEUTICA SPAIN, S.A.	5	€13,965,921	2026-09-10
ROCHE FARMA, S.A. UNIPERSONAL	4	€130,837,823	2026-09-08
EDWARDS LIFESCIENCIES, S.L. \| ABBOTT MEDICAL ESPAÑA SA \| MEDTRONIC IBÉRICA, S.A. \| BOSTON SCIENTIFIC IBÉRICA, S.A. \| MERCÉ V. ELECTROMEDICINA, S.L. \| PALEX MEDICAL \| SAGITTAE MEDICAL S.L \| SERMEBI 97 SL	4	€32,112,843	2026-09-10
ABBOTT MEDICAL ESPAÑA, S.A. \| BARD DE ESPAÑA, S.L. \| BOSTON SCIENTIFIC IBÉRICA, S.A. \| CARDINAL HEALTH SPAIN 511, S.L. \| CARDIVA 2, S.L. \| MEDTRONIC \| BIOTRONIK SPAIN, S. A. \| PRIM, S.A. \| LOGSA \| LEXEL S L \| TERUMO \| COOK ESPAÑA, S.L. \| LOGIMED SL \| MERIT MEDICAL SPAIN, S.L.U. \| W.L. GORE Y ASOCIADOS, S.L. \| INNOVASC INTEGRAL SOLUTIONS SL \| GETINGE GROUP SPAIN, S.L. \| DGM VASCULAR SL \| CIRCINORMED, S.L. \| BIOSENSORS IBERIA S L \| IZASA HOSPITAL, S.L. \| WORLD MEDICA S.L.	4	€16,261,176	2026-09-11
JANSSEN CILAG, S.A.	3	€188,990,947	2026-08-31

Full buyer profile: what OSAKIDETZA - Servicio Vasco de Salud - Organización Central buys and who wins it →

CPV codes

33600000 Medical equipment & pharmaceuticals

Description

Suministro de Tafamidis (DOE) y Crizotinib (DOE)

Similar tenders

Closest by meaning — across languages, via embeddings.

Published	Title	Buyer	Match
2026-07-08	Suministro de Tafasitamab (DOE)	OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES	97%
2026-07-22	Suministro de Acoramidis (DOE) y Darolutamida (DOE)	OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES	97%
2026-06-17	Suministro de Axitinib (DOE) y Gemtuzumab ozogamicina (DOE)	OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES	96%
2026-09-03	Suministro de Emicizumab (DOE) y Risdiplam (DOE)	OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES	96%
2026-05-05	Suministro de Eribulina (DOE) Y Lenvatinib (DOE)	OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES	96%
2026-05-04	Suministro de Uroquinasa (DOE) y Natalizumab (DOE)	OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES	96%

Source

View the official notice on TED ↗